Company registration number 09742753 (England and Wales)
AVANT HEALTHCARE GLOBAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
AVANT HEALTHCARE GLOBAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
AVANT HEALTHCARE GLOBAL LIMITED
BALANCE SHEET
AS AT
31 JULY 2025
31 July 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
3
300,100
300,100
Current assets
Debtors
4
100
100
Creditors: amounts falling due within one year
5
(299,200)
(299,200)
Net current liabilities
(299,100)
(299,100)
Net assets
1,000
1,000
Capital and reserves
Called up share capital
6
1,000
1,000

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 31 March 2026 and are signed on its behalf by:
S M Graham
Director
Company registration number 09742753 (England and Wales)
AVANT HEALTHCARE GLOBAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 2 -
1
Accounting policies
Company information

Avant Healthcare Global Limited is a private company limited by shares incorporated in England and Wales. The registered office is 22 Wycombe End, Beaconsfield, Buckinghamshire, HP9 1NB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ”Basic Financial Instruments” to all of its financial instruments.

Financial instruments are recognised in the company’s balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Short term debtors are measured at transaction price less any provision for impairment. Loans receivable are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method, less any provision for impairment.

Basic financial liabilities

Short term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method.

AVANT HEALTHCARE GLOBAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
300,100
300,100
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
100
100
5
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
299,200
299,200
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1,000
1,000
1,000
1,000

2025-07-31 2024-08-01 false false false CCH Software CCH Accounts Production 2025.300 No description of principal activity S M Graham D R Dungar 09742753 2024-08-01 2025-07-31 09742753 2025-07-31 09742753 2024-07-31 09742753 core:CurrentFinancialInstruments 2025-07-31 09742753 core:CurrentFinancialInstruments 2024-07-31 09742753 core:ShareCapital 2025-07-31 09742753 core:ShareCapital 2024-07-31 09742753 core:ShareCapitalOrdinaryShareClass1 2025-07-31 09742753 core:ShareCapitalOrdinaryShareClass1 2024-07-31 09742753 bus:Director1 2024-08-01 2025-07-31 09742753 2023-08-01 2024-07-31 09742753 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 09742753 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 09742753 bus:OrdinaryShareClass1 2024-08-01 2025-07-31 09742753 bus:OrdinaryShareClass1 2025-07-31 09742753 bus:OrdinaryShareClass1 2024-07-31 09742753 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09742753 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09742753 bus:FRS102 2024-08-01 2025-07-31 09742753 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09742753 bus:Director2 2024-08-01 2025-07-31 09742753 bus:FullAccounts 2024-08-01 2025-07-31 xbrli:pure xbrli:shares iso4217:GBP